Projet MOGLYNET (Horizon 2020, appel à projets 2015)
Action : Doctoral Networks - Joint Doctorates
Panel : Life Sciences
Statut du projet : CLOSED

The mission of MoGlyNet is to define a joint doctorate educational training model in Drug Discovery and Development where Academia and Industry join their forces for: - creating a common platform of knowledge and language for early stage researchers (ESR) working in the Drug Discovery and Development area aiming to convey complementary pharma-skills - exploiting this platform to train a new generation of cutting-edge researchers and professionals highly attractive for employment by the European Pharma-industry - establishing structures for long-term cooperation, strengthening the relationships among the leading Universities and Pharma-enterprises and to continuously develop the research training platform that European industry relies on. To achieve the above objectives the main tasks of MoGlyNet are: - to attract/train 12 ESRs in optimization joint academic/industrial program of cutting-edge training-by-research, high quality supervision, complementary and transferable Pharma-skills training, inter-network secondments, and workshops/Summer Schools - to pursue an innovative research project that will tackle a timely and important scientific problem with a multidisciplinary approach (from molecular modelling to in vivo studies). Atherosclerosis is an aging-related disease and our research approach for a better therapy of atherosclerosis will be focused on the PFKFB3 enzyme, a key player in glycolysis/oxidative stress and therefore in pathological angiogenesis - to build a solid foundation for long-term European excellence in this field by disseminating MoGlyNet research/training outcomes and best practice into the partners Doctoral Schools, and by fostering long-term partnerships and collaborations that will outlast the Consortium - to transfer expertise/know-how among the Consortium participants and to external groups via networking activities, intersectorial exposure, secondments, workshops, sharing of learning material, public engagement and outreach activities

Mots clés : molecular modelling, synthesis of small molecules, peptide, peptidomimetics, diagnostic tools  imaging, oxidative stress

Participants :
- University of Barcelona (Espagne) — Partner, beneficiary, Enseignement supérieur ou secondaire, subvention : 495745.92 €
- Ppd italy s.r.l. (Italie) — Partner, organization partner, Organismes privés (hors enseignement), subvention : 0.0 €
- Biomax Informatics (Germany) (Allemagne) — Partner, organization partner, Organismes privés (hors enseignement), subvention : 0.0 €
- Leiden University Medical Center (Pays-Bas) — Partner, beneficiary, Enseignement supérieur ou secondaire, subvention : 510748.56 €
- Linkcare health services sl (Espagne) — Partner, organization partner, Organismes privés (hors enseignement), subvention : 0.0 €
- Kemotech srl (Italie) — Partner, organization partner, Organismes privés (hors enseignement), subvention : 0.0 €
- University of Antwerp (Belgique) — Partner, beneficiary, Enseignement supérieur ou secondaire, subvention : 501120.0 €
- Phramintraco (Suisse) — Partner, organization partner, Organismes privés (hors enseignement), subvention : 0.0 €
- University of Aberdeen (Royaume-Uni) — Partner, beneficiary, Enseignement supérieur ou secondaire, subvention : 546575.76 €
- University of Milan (Italie) — Coordinator, beneficiary, Enseignement supérieur ou secondaire, subvention : 1032245.28 €
- Bayer (Italy) (Italie) — Partner, organization partner, Organismes privés (hors enseignement), subvention : 0.0 €
- Histogenex n.v. (Belgique) — Partner, organization partner, Organismes privés (hors enseignement), subvention : 0.0 €
- Ass des pharmaciens de l industrie (France) — Partner, organization partner, Organismes privés (hors enseignement), subvention : 0.0 €